Dung Nguyen, MD, PharmD
Dung Nguyen, MD, PharmD
Palo Alto, California, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery | Breast Cancer Lymphedema, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, lymphatic system disorder, lymphedema | Recruiting | Not applicable | 2021-05-20 | NCT04888975 |